U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Nanotechnology Programs at FDA
  5. Center for Devices and Radiological Health Nanotechnology Programs
  1. Nanotechnology Programs at FDA

Center for Devices and Radiological Health Nanotechnology Programs

The Center for Devices and Radiological Health (CDRH) continues to build the Center’s knowledge base and experimental expertise regarding nanotechnology, including through collaborating on research projects with other stakeholders. All research projects related to nanotechnology are currently conducted in the Office of Science and Engineering Laboratories.

CDRH nanotechnology regulatory science research projects are primarily addressing the following:

  • Understanding the mechanistic behavior of nanomaterials from physical, chemical and biological aspects including:

    Physico-chemical stability/interaction of nanomaterials and their interaction with nanoscale surfaces; Toxicity and behavior of nanomaterials in in-vitro and in-vivo environments; Biocompatibility of nanomaterials exposed to blood elements; and Gene expression models for evaluating adverse reactions to nanomaterials. A number of these studies are being conducted using silver nanomaterials as silver is used in many devices for its antimicrobial properties.

  • Advancing knowledge regarding the characterization of nanomaterials including:

    Existing methods/technologies for characterization of nanomaterials and their limitations; Characterization of optical coherence tomography-based imaging approaches; and Optical nanobiosensors for minimally invasive intracellular monitoring.

For further information:

CDRH-Center for Devices and Radiological Health
Food and Drug Administration
10903 New Hampshire Avenue
WO66-5429
Silver Spring, MD 20993
Telephone: 1-800-638-2041
Email: dice@fda.hhs.gov OR (DICE)

Back to Top